Effects of Milk Protein and Vitamin D on Children's Growth and Health

NCT03956732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-04-15

No results posted yet for this study

Summary

The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.

Conditions

  • Bone Health
  • Muscle Function
  • Cardiometabolic Health
  • Appetite Regulation

Interventions

DIETARY_SUPPLEMENT

Milk Protein (high)

High protein yoghurt which contains approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.

DIETARY_SUPPLEMENT

Vitamin D

One daily tablet containing 20 μg of vitamin D3, cholecalciferol.

DIETARY_SUPPLEMENT

Milk Protein (medium)

Ordinary yoghurt containing approx. 3.3 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.

Sponsors & Collaborators

  • University of Aarhus

    collaborator OTHER
  • Arla Foods

    collaborator INDUSTRY
  • Arla Foods Ingredients

    collaborator UNKNOWN
  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Camilla T Damsgaard, Assoc Prof · Department of Nutrition, Exercise and sports, University of Copenhagen

  • Christian Mølgaard, Prof · Department of Nutrition, Exercise and sports, University of Copenhagen

  • Mette Hansen, Assoc Prof · Institute of Public Health, Aarhus University, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
6 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2020-04-03
Completion
2020-04-03

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03956732 on ClinicalTrials.gov